Court Unseals Key Evidence in Coventry Filing Showing Abacus Global Management Relied on Short Lapetus Life Expectancy Estimates and Misled Investors

A U.S. District Court unsealed documents in litigation between Coventry and Abacus Global Management revealing that Abacus knowingly relied on significantly underestimated life expectancy data from Lapetus Solutions and misled investors about a Lewis & Ellis valuation report. Lapetus showed a 41.5% actual-to-expected mortality ratio compared to industry standards near 100%, and Abacus allegedly manipulated the Lewis & Ellis report by using different discount rates and withholding life expectancy estimates to inflate portfolio valuations.